Close Menu
  • Home
  • Markets
    • Earnings
  • Banks
    • Crypto
    • Investing
  • Business
    • Retail
  • industry
    • Finance
    • Energy
    • Real Estate
  • Politics
  • Editorials
Facebook X (Twitter) Instagram
Facebook LinkedIn
Financial Market News
Subscribe Now
  • Home
  • Markets
    • Earnings
  • Banks
    • Crypto
    • Investing
  • Business
    • Retail
  • industry
    • Finance
    • Energy
    • Real Estate
  • Politics
  • Editorials
Financial Market News
You are at:Home»Posts Tagged "GSK plc"

Trump tariffs fall, but trade war impacts linger

By FinMar NewsApril 3, 2026

A year after President Donald Trump declared his “liberation day” and imposed sweeping tariffs on imports, kicking off a wave of economic and political uncertainty, some…

Trump health care plan likely good for pharmaceutical companies

By FinMar NewsJanuary 26, 2025

U.S. President Donald Trump speaks about prescription drug prices during an appearance in the Brady Press Briefing Room at the White House in Washington, U.S., November…

Medicare drug price negotiations list includes Ozempic

By FinMar NewsJanuary 18, 2025

A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating Type 2 diabetes made by Novo Nordisk, at Rock Canyon Pharmacy in Provo,…

Vaccine maker stocks fall as Trump chooses RFK Jr. to lead HHS

By FinMar NewsNovember 15, 2024

Robert F. Kennedy Jr. in Phoenix on Aug. 23, 2024.Thomas Machowicz | ReutersShares of vaccine makers fell Thursday as President-elect Donald Trump nominated Robert F. Kennedy…

Merck says experimental RSV treatment protected infants in trial

By FinMar NewsOctober 18, 2024

The logo for Merck is displayed on a screen at the New York Stock Exchange on Nov. 17, 2021.Andrew Kelly | ReutersMerck on Thursday said its…

FDA approves Merck pneumococcal disease vaccine designed for adults

By FinMar NewsJune 17, 2024

Zoom In IconArrows pointing outwardsMerck’s new pneumococcal vaccine. Courtesy: MerckThe Food and Drug Administration on Monday approved Merck’s new vaccine designed to protect adults from a…

FDA approves GSK RSV vaccine for adults 50 to 59

By FinMar NewsJune 7, 2024

A view shows GlaxoSmithKline headquarters in London, Britain, January 17, 2022.Hannah Mckay | ReutersThe Food and Drug Administration on Friday expanded the approval of GSK’s respiratory…

FDA approves Moderna RSV vaccine for seniors

By FinMar NewsJune 2, 2024

The FDA has approved Moderna’s RSV vaccine for older adults.Courtesy: ModernaThe Food and Drug Administration on Friday approved Moderna’s vaccine for respiratory syncytial virus for adults…

FTC challenges patents held by drugmakers, including for Ozempic

By FinMar NewsApril 30, 2024

A box of Ozempic and contents sit on a table in Dudley, North Tyneside, Britain, October 31, 2023. Lee Smith | ReutersThe Federal Trade Commission on Tuesday…

Energy News

U.S. urges citizens to rethink Middle East travel as Iran tensions rise

Energy Costs Divide Curry, Otis at Climate Forum | News

Brent, WTI, Saudi Arabia, Houthi

The Iran war is driving clean energy development. It’s not enough to help

Banks News

Islamic banks shielded by solid buffers amid regional tensions —

The FE – Strong governance, supervision crucial to banking reforms

NBK launches ‘NBK Reach’ for Kuwaiti students in UK

Industry moves: Wellington-Altus adds Saint John advisor team

Real Estate News

China A-Shares Close Higher Across the Board on Sept. 21; Real Estate,

Elvis Superfan Snaps Up Graceland-Inspired Home for $150K

SC law needs clarity on when apartments get a tax break

Law firm tees up class action linked to MRED-Compass deal

© 2026 finmar.news

Type above and press Enter to search. Press Esc to cancel.

Social Media Auto Publish Powered By : XYZScripts.com